Analyst Ratings For NuVasive (NASDAQ:NUVA)
Today, Canaccord Genuity reiterated its Buy rating on NuVasive (NASDAQ:NUVA) with a price target of $75.00.
There are 1 sell rating, 2 hold ratings, 11 buy ratings on the stock.
The current consensus rating on NuVasive (NASDAQ:NUVA) is Buy (Score: 2.71) with a consensus target price of $73.58 per share, a potential 34.79% upside.
Some recent analyst ratings include
- 10/25/2017-Canaccord Genuity Reiterated Rating of Buy.
- 10/12/2017-Leerink Swann Reiterated Rating of Outperform.
- 10/10/2017-Royal Bank Of Canada Reiterated Rating of Buy.
- 10/6/2017-Needham & Company LLC Reiterated Rating of Sell.
- On 8/29/2017 Gregory T Lucier, CEO, bought 2,000 with an average share price of $61.52 per share and the total transaction amounting to $123,040.00. View SEC Filing
- On 8/18/2017 Lesley H. Howe, Director, sold 3,970 with an average share price of $64.64 per share and the total transaction amounting to $256,620.80. View SEC Filing
- On 8/17/2017 Gregory T Lucier, CEO, bought 5,000 with an average share price of $66.22 per share and the total transaction amounting to $331,100.00. View SEC Filing
- On 8/1/2017 Peter Michael Leddy, EVP, bought 7,850 with an average share price of $63.88 per share and the total transaction amounting to $501,458.00. View SEC Filing
- On 3/8/2017 Jason Hannon, Insider, sold 24,840 with an average share price of $74.22 per share and the total transaction amounting to $1,843,624.80. View SEC Filing
- On 2/14/2017 Lesley H. Howe, Director, sold 6,049 with an average share price of $73.26 per share and the total transaction amounting to $443,149.74. View SEC Filing
- On 12/12/2016 Matthew Link, Insider, sold 10,303 with an average share price of $67.99 per share and the total transaction amounting to $700,500.97. View SEC Filing
Recent Trading Activity for NuVasive (NASDAQ:NUVA)
Shares of NuVasive closed the previous trading session at with shares trading hands.